It was a great honor to be one of the first two physicians to receive the initial Certificate of Interventional Endocrinology (CIE) at NASOIE, alongside Dr. Agustin Andrade. # NASOIE #CIE #MIE Read...
Major update: Dr. Aljammal, in this study, is investigating potential factors that may influence volume reduction (VR) following radiofrequency ablation (RFA) in patients with benign thyroid nodules. Click Here to read my findings This is a multicenter, retrospective...
Major update: Dr. Aljammal recently published the largest multicenter data in the USA on the treatment of benign and toxic thyroid nodules in the Journal of the Endocrine Society. This provides valuable insight to physicians and patients worldwide regarding the...
Recent studies report the incidence of intrathyroidal parathyroid adenoma to be between 1–3%. Radiofrequency ablation offers a targeted therapy that spares the surrounding healthy thyroid...
Dr. Aljammal joined international experts in a discussion of radiofrequency ablation. He presented the largest and first data on the treatment of toxic benign thyroid nodules in the USA. Conclusion Radio Frequency should be considered as a first-line treatment for...
